Clinical Guidelines

While the 2021 American College of Rheumatology rheumatoid arthritis recommendations improved over the 2015 document, understanding the weaknesses and limitations of the most recent iteration can be beneficial, according to a presenter here.

An expert panel has developed recommendations on best practices for managing clinically relevant immune-related adverse events associated with immune checkpoint inhibitor treatment.

National Comprehensive Cancer Network updated its guidance on COVID-19 vaccination for patients with cancer following FDA authorization of a third mRNA vaccine dose for certain immunocompromised individuals.

A joint study conducted by the National Kidney Foundation and Labcorp revealed that 80.3% of patients who should have been tested for chronic kidney disease according to clinical practice guidelines did not receive appropriate testing.

American Society for Radiation Oncology issued its first clinical guideline for sarcoma.

The FDA has authorized emergency use of baricitinib alone for the treatment of adults and pediatric patients aged 2 years and older who are hospitalized with COVID-19.

An updated position statement issued by the American Academy of Neurology about ethical considerations that often arise in the treatment of patients with dementia revises the organization’s statement from 1996 on the same topic.

ASCO issued a guideline update that recommends offering 1-year of adjuvant olaparib to certain patients with breast cancer.

Routine care for inflammatory arthritis should include self-management strategies that feature problem-solving, goal-setting and, if possible, cognitive behavioral therapy, according to new EULAR recommendations.

Health care providers should perform diagnostic tests to determine the cause of a first stroke within 48 hours of symptom onset, according to an updated American Heart Association and American Stroke Association Clinical Practice Guideline.